Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1148/radiol.2363050565 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Iron deficiency and iron deficiency anemia in transgender populations: what's different?
Clin Chem Lab Med
November 2024
Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.
What's new in osteoporosis management? Leading the fight in primary care.
Br J Gen Pract
October 2024
School of Medicine, Keele University, Keele.
What's New in Osteoporosis: Emphasis on the Aging Athlete.
J Bone Joint Surg Am
September 2024
Metabolic Bone Disease Service, Department of Orthopedics, Hospital for Special Surgery, New York, NY.
The therapeutic mechanism of Compound Lurong Jiangu Capsule for the treatment of cadmium-induced osteoporosis: network pharmacology and experimental verification.
Front Endocrinol (Lausanne)
July 2024
Changchun University of Chinese Medicine, Changchun, Jilin, China.
Background: Among bone diseases, osteoporosis-like skeleton, such as trabecular thinning, fracture and so on, is the main pathological change of cadmium-induced osteoporosis(Cd-OP), accompanied by brittle bone and increased fracture rate. However, the mechanism underlying cadmium-induced osteoporosis has remained elusive. Compound Lurong Jiangu Capsule (CLJC) is an experienced formula for the treatment of bone diseases, which has the effect of tonifying kidney and strengthening bones, promoting blood circulation and relieving pain.
View Article and Find Full Text PDFIcariin upregulates methyltransferase-like 14-mediated prolyl 4-hydroxylase beta subunit m6A modification to promote osteogenic differentiation of bone marrow stem cells.
Exp Cell Res
July 2024
Department of Microscopic Orthopaedics, Affiliated Hospital of Shandong University of Chinese Medicine, Jinan, 250014, Shandong Province, PR China. Electronic address:
Prolyl 4-hydroxylase beta subunit (P4HB) plays a vital role in bone formation. This study intends to clarify the role of P4HB in the therapeutic effect of Icariin (ICA) on osteoporosis. Herein, in vivo and in vitro models were constructed by performing ovariectomy (OVX) in rats and inducing osteogenic differentiation in bone marrow stem cells (BMSCs), respectively.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!